X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (151) 151
Publication (20) 20
Book / eBook (9) 9
Book Chapter (5) 5
Patent (2) 2
Book Review (1) 1
Dissertation (1) 1
Technical Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (36) 36
oncology (26) 26
hematology (22) 22
male (20) 20
female (17) 17
aged (15) 15
lymphomas (15) 15
adult (14) 14
treatment outcome (14) 14
middle aged (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
b-cell lymphoma (11) 11
risk factors (11) 11
lymphoma (10) 10
rituximab (10) 10
abridged index medicus (9) 9
cancer (9) 9
transplantation (9) 9
antineoplastic agents - therapeutic use (8) 8
article (8) 8
chemotherapy (8) 8
physics (8) 8
active antiretroviral therapy (7) 7
animals (7) 7
history (7) 7
non-hodgkins-lymphoma (7) 7
clinical trials as topic (6) 6
disease-free survival (6) 6
follicular lymphoma (6) 6
non-hodgkin-lymphoma (6) 6
therapy (6) 6
young adult (6) 6
aged, 80 and over (5) 5
analysis (5) 5
apoptosis (5) 5
care and treatment (5) 5
cell biology (5) 5
drug therapy (5) 5
expression (5) 5
further section (5) 5
general relativity and quantum cosmology (5) 5
hematopoietic stem cells (5) 5
lymphoma, aids-related - mortality (5) 5
mutation (5) 5
non-hodgkin lymphoma (5) 5
phase-ii (5) 5
phase-ii trial (5) 5
progression-free survival (5) 5
recurrence (5) 5
retrospective studies (5) 5
stem cells (5) 5
survival (5) 5
acquired immunodeficiency syndrome (4) 4
aids (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
chronic lymphocytic-leukemia (4) 4
era (4) 4
gene expression (4) 4
hematology, oncology and palliative medicine (4) 4
hematopoietic stem cell transplantation (4) 4
hemic and lymphatic diseases (4) 4
hiv (4) 4
immunotherapy (4) 4
leukemia (4) 4
lymphoma, aids-related - drug therapy (4) 4
multivariate analysis (4) 4
non‐hodgkin lymphoma (4) 4
physics, multidisciplinary (4) 4
prognosis (4) 4
radiation (4) 4
survival rate (4) 4
transplantation, autologous (4) 4
adolescent (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antineoplastic agents (3) 3
astrophysics (3) 3
autografts (3) 3
autologous transplantation (3) 3
biopsy (3) 3
bone marrow (3) 3
burkitt lymphoma (3) 3
chop (3) 3
cyclophosphamide (3) 3
cyclophosphamide - therapeutic use (3) 3
diagnosis (3) 3
diffuse large b-cell lymphoma (3) 3
diffuse large b‐cell lymphoma (3) 3
disease (3) 3
disease progression (3) 3
dose-adjusted epoch (3) 3
doxorubicin - therapeutic use (3) 3
genetic aspects (3) 3
hogs (3) 3
human-immunodeficiency-virus (3) 3
immunochemotherapy (3) 3
intensive chemotherapy (3) 3
kaplan-meier estimate (3) 3
lactic acid (3) 3
materials science, multidisciplinary (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2019, Volume 134, Issue 26, pp. 2339 - 2345
The development of brentuximab vedotin has opened a new era in the management of peripheral T-cell lymphomas (PTCLs). The improved outcomes with brentuximab... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1595 - 1595
Background: Plasmablastic lymphoma (PBL) is an aggressive large B-cell lymphoma commonly associated with HIV, immunosuppression, old age, and autoimmune... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2017, Volume 92, Issue 10, pp. 1047 - 1051
Journal Article
2016, 1st ed. 2016, ISBN 9783319268552, 239
This book presents a general introduction to and review of HIV-associated hematological malignancies, with a special focus on practical management issues. Each... 
Clinical & internal medicine | Viral carcinogenesis | Oncology | Medicine & Public Health | Hematology | HIV infections | Blood
eBook
2016, 1st ed. 2016., ISBN 9783319268552
This book presents a general introduction to and review of HIV-associated hematological malignancies, with a special focus on practical management issues. Each... 
Medicine | Hematology | Oncology
Web Resource
Current Hematologic Malignancy Reports, ISSN 1558-8211, 8/2019, Volume 14, Issue 4, pp. 239 - 246
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 3053 - 3053
Abstract Introduction The International Prognostic Index (IPI) and the age-adjusted IPI (aaIPI) are the most commonly used tools to predict outcomes in... 
Journal Article
Future Oncology, ISSN 1479-6694, 12/2014, Volume 10, Issue 15, pp. 2509 - 2528
ABSTRACT Lymphomas are the most common hematologic malignancies with approximately 79,000 new cases estimated for 2013 in the USA. Despite improved outcomes,... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e19548 - e19548
Journal Article
North American Journal of Medical Sciences, ISSN 2250-1541, 07/2013, Volume 5, Issue 7, pp. 438 - 439
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 10/2017, Volume 17, Issue 10, pp. 650 - 657
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 640 - 640
Abstract Background DHL are high-grade B-cell lymphomas (BCL) characterized by dual gene rearrangements (RA) of MYC and either BCL2 or BCL6. Outcomes are... 
Journal Article
Blood, ISSN 0006-4971, 10/2014, Volume 124, Issue 15, pp. 2354 - 2361
Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a... 
REARRANGEMENT | SURVIVAL | TRANSLOCATION | POOR-PROGNOSIS | RITUXIMAB | MYC | PHASE-II | GERMINAL CENTER | INDEX | HEMATOLOGY | EXPRESSION | Multivariate Analysis | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Remission Induction | Stem Cell Transplantation | Young Adult | Disease-Free Survival | Lymphoma - therapy | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 05/2018, Volume 58, Issue 2, pp. 1 - 12
Proteasome inhibitors disrupt multiple pathways in cells and the bone marrow microenvironment, resulting in apoptosis and inhibition of cell-cycle progression,... 
ADVANCED SOLID TUMORS | UBIQUITIN-MEDIATED PROTEOLYSIS | DOSE DEXAMETHASONE | PHASE-I TRIAL | PROTEASOME INHIBITOR BORTEZOMIB | POTENTIAL-DRUG INTERACTIONS | NATIONAL-CANCER-INSTITUTE | PHARMACOLOGY & PHARMACY | RELAPSED MULTIPLE-MYELOMA | WALDENSTROM MACROGLOBULINEMIA | SYSTEMIC AL AMYLOIDOSIS
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3682 - 3682
Abstract Abstract 3682 Background: Non-Hodgkin Lymphoma (NHL) remains the most common malignancy in patients with HIV infection, but there are few randomized... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5261 - 5261
Introduction: Acalabrutinib (acala), a Bruton's Tyrosine Kinase inhibitor (BTKi), received accelerated FDA approval for treatment of mantle cell lymphoma (MCL)... 
Journal Article
Future oncology (London, England), 12/2014, Volume 10, Issue 15, p. 2509
Lymphomas are the most common hematologic malignancies with approximately 79,000 new cases estimated for 2013 in the USA. Despite improved outcomes, relapse or... 
Lymphoma - diagnosis | Prognosis | Signal Transduction | Epigenesis, Genetic | Humans | Lymphoma - genetics | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Lymphoma - drug therapy | Animals | Cell Cycle | Immunotherapy | Antineoplastic Agents - pharmacology | Mutation
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.